Upgrade to SI Premium - Free Trial

'Eli Lilly (LLY) Extends Its Lead Into 2026'; PT Raised to $1,300 at BMO Capital

February 5, 2026 9:12 AM
BMO Capital analyst Evan Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $1,300.00 (from $1,200.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles